Clinical Trials Sponsored by AOK

Total 392 results

ABK Biomedical

Recruiting

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Liver Cancer | Hepatocellular Carcinoma Non-resectable

United States
ABK Biomedical

Completed

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRC

Metastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectable

New Zealand
Ask Rose

Unknown

Examining the Feasibility of a Mobile Mental Health Application in Psychotherapy

Depression | Mental Health Wellness 1

United States
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Hypertrophic Scar

China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Completed

A Study of AK3280 in Chinese Healthy Volunteers

Healthy

China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
Ark Biosciences Inc.

Completed

A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers

Healthy

China
Oak Valley Health

Recruiting

ED Adaptive Staffing Study (FAST-ED)

Emergency Medicine | Well-Being, Psychological

Canada
Ark Biosciences Inc.

Unknown

Anti-RSV Study in Chinese Patients (ASCENT) (ASCENT)

Respiratory Syncytial Virus Infections

China
Ark Biosciences Inc.

Completed

A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529

Healthy

United Kingdom
Ark Biosciences Inc.

Completed

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects

Healthy Subjects

United States
Ark Biosciences Inc.

Completed

A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects

Healthy

Sweden
Ark Biosciences Inc.

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

Australia
Ark Biosciences Inc.

Completed

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Respiratory Syncytial Virus Infections

Australia
Ark Therapeutics Ltd

Terminated

Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence (AdV-VANTAGE)

End Stage Renal Disease

United States
Shanghai Ark Biopharmaceutical Co., Ltd.
Ark Biosciences Pty Ltd.

Completed

Viral Inhibition in Children for Treatment of RSV (VICTOR)

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Australia, Hong Kong, Israel, Lebanon, Malaysia, Poland, Taiwan, Turkey
ALK-Abelló A/S

Recruiting

Observational Study of Allergic Rhinitis in Children (ORACLE)

Allergic Rhinitis

France
ALK-Abelló A/S

Active, not recruiting

House Dust Mite Allergy Trial In Children (MATIC)

Allergic Rhinitis Due to Dermatophagoides Farinae | Allergic Rhinitis Due to Dermatophagoides Pteronyssinus | Allergic Rhinitis Due to House Dust Mite

Spain, Russian Federation, United States, Poland, Bulgaria, Canada, France, Germany, Lithuania, Slovakia, Ukraine
AOP Orphan Pharmaceuticals AG

Completed

Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera (PEGINVERA)

Polycythemia Vera

Austria
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

Allergic Rhinitis Due to Grass Pollens

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet (MT-06)

House Dust Mite Allergy

France
AOP Orphan Pharmaceuticals AG

Completed

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia (ARETA)

Essential Thrombocythaemia

Poland, Slovakia, Bulgaria, Russian Federation, Romania, Croatia, Lithuania, Austria, Ukraine
ALK-Abelló A/S

Completed

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

Allergy

Germany
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

Atopic Dermatitis

Germany
AOP Orphan Pharmaceuticals AG

Completed

Anagrelide Retard in Essential Thrombocythemia (TEAM-ET)

Essential Thrombocythemia

Austria, Bulgaria, Lithuania, Poland, Russian Federation
AOP Orphan Pharmaceuticals AG

Completed

Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers

Healthy

Czech Republic
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

Birch Pollen Allergy

Finland, Netherlands
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever

Allergy

Germany
ALK-Abelló A/S

Completed

Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Asthma | Rhinitis | Conjunctivitis

Germany
ALK-Abelló A/S

Completed

Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch

Allergy

Germany
Keryx / AOI Pharmaceuticals, Inc.

Terminated

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Glioma | Astrocytoma | Oligoastrocytoma | Oligodendroglioma

United States
ALK-Abelló A/S

Completed

Tolerability of Grazax in Patients With Hayfever in Real Life Settings (GRAAL)

Allergic Rhinoconjunctivitis

France
ALK-Abelló A/S

Completed

Efficacy of SLITone in House Dust Mite Allergic Patients

Allergy

Spain
AOP Orphan Pharmaceuticals AG

Completed

Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia (ANAHYDRET)

Essential Thrombocythaemia

Austria, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Poland, Singapore, Slovenia
ALK-Abelló A/S

Completed

Efficacy and Safety of Grazax in Children

Allergy

Germany
ALK-Abelló A/S

Completed

Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma

Allergic Asthma

Spain
ALK-Abelló A/S

Completed

Tolerability of ALK Tree Tablet

Allergy

Denmark
ALK-Abelló A/S

Completed

Tolerability of Grazax-R in Children

Allergy

Germany
ALK-Abelló A/S

Completed

Tolerability of ALK Grass Tablet in Children

Allergy

Spain
AOP Orphan Pharmaceuticals AG

Not yet recruiting

Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH

Pulmonary Arterial Hypertension

Spain, Austria, France, Hungary
ALK-Abelló A/S

Enrolling by invitation

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

Allergic Asthma | Allergic Rhinitis Due to House Dust Mite

China
Oak Hill Bio Ltd

Terminated

Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants

Intraventricular Hemorrhage | Bronchopulmonary Dysplasia | Chronic Lung Disease of Prematurity | Retinopathy of Prematurity (ROP)

United States, Italy, United Kingdom
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® (GT-20)

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) (AIRS)

Allergic Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)

Allergy

Clinical Trials Sponsored by AOK

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations